Raymond James Financial Services Advisors’s Transmedics TMDX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$4.03M	Sell	25,677 -3,596	-12%	-$554K	0.01%	1346
2024 Q2	$4.41M	Buy	29,273 +1,696	+6%	+$203K	0.01%	1237
2024 Q1	$2.04M	Buy	27,577 +10,325	+60%	+$851K	﹤0.01%	1631
2023 Q4	$1.36M	Buy	17,252 +5,515	+47%	+$333K	﹤0.01%	1797
2023 Q3	$643K	Sell	11,737 -2,404	-17%	-$173K	﹤0.01%	2162
2023 Q2	$1.19M	Buy	+14,141	New	+$1.08M	﹤0.01%	1813

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Raymond James Financial Services Advisors's TMDX Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Transmedics (TMDX) stake by 12% in Q3 2024, selling an estimated $554K and leaving 25,677 shares worth $4.03M. The position accounts for 0.01% of the portfolio, ranked #1346.

Raymond James Financial Services Advisors first reported a position in TMDX in Q2 2023 and has held it in 6 quarters since. The position peaked at $4.41M in Q2 2024. 373 funds tracked by Wall St. Rank hold TMDX as of Q3 2024.

Raymond James Financial Services Advisors held 25,677 shares of Transmedics worth $4.03M as of Q3 2024.
Raymond James Financial Services Advisors sold 3,596 Transmedics shares in Q3 2024, an estimated $554K.
Transmedics made up 0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1346 holding.
Raymond James Financial Services Advisors first reported a position in Transmedics in Q2 2023 and has held it in 6 quarters since.
Raymond James Financial Services Advisors's Transmedics position peaked at $4.41M in Q2 2024.
373 funds tracked by Wall St. Rank held Transmedics as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.